Physician profile
Seth D Oesch
NPI 1427030188
$1,148.40
in general payments reported to CMS, 2019-2025
15 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.20 · 2022: $39.90 · 2023: $291 · 2024: $492 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $235.72 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $169.92 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $162.35 | 2023-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $152.01 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $71.36 | 2023-2025 | Ozempic, Rybelsus |
| Almatica Pharma LLC | $69.06 | 2023 | Loreev Xr |
| Novartis Pharmaceuticals Corporation | $53.01 | 2024 | |
| Abbott Laboratories | $52.03 | 2023-2025 | Freestyle Libre 3, Octrode |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.95 | 2023-2024 | Jardiance |
| Pfizer INC. | $39.87 | 2022-2025 | |
| Eisai INC. | $27.08 | 2024 | |
| Exact Sciences Corporation | $21.03 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic, INC. | $19.81 | 2022 | |
| Boston Scientific Corporation | $18.60 | 2021 | |
| Biosense Webster, INC. | $16.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Oesch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.